搜尋結果
Some people who have taken apoaequorin have reported potential side effects to a manufacturer of the product. Some of the most commonly reported side effects were headache, dizziness, and nausea. Others less common events were memory problems, difficulty sleeping, and anxiety. There have also been a smaller number of reports of more serious ...
Constipation. The dark color of urine. Other rare side effects include: Lethargy /tiredness. Ataxia (lack of muscle control or coordination of voluntary movements) Seizures (sudden uncontrolled electrical disturbance in the brain) Vertigo (sensation of feeling off-balance) Dizziness/ unsteadiness. Mood changes.
- General
- Laboratory Tests
- Carcinogenesis, Mutagenesis, Impairment of Fertility
- Pregnancy
- Pediatric Use
- Geriatric Use
Oral Fansidar (sulfadoxine and pyrimethamine) has not been evaluated for the treatment of cerebral malaria or other severe manifestations of complicated malaria, including hyperparasitemia, pulmonary edema or renal failure. Patients with severe malaria are not candidates for oral therapy. In the event of recrudescent P. falciparuminfections after t...
Regularly scheduled complete blood counts, liver enzyme tests and analysis of urine for crystalluria should be performed whenever Fansidar (sulfadoxine and pyrimethamine) is administered for more than three months.
Pyrimethamine was not found carcinogenic in female mice or in male and female rats. The carcinogenic potential of pyrimethamine in male mice could not be assessed from the study because of markedly reduced life-span. Pyrimethamine was found to be mutagenic in laboratory animals and also in human bone marrowfollowing 3 or 4 consecutive daily doses t...
Fansidar (sulfadoxine and pyrimethamine) has been shown to be teratogenicin rats when given in weekly doses approximately 12 times the weekly human prophylactic dose. Teratology studies with pyrimethamine plus sulfadoxine (1:20) in rats showed the minimum oral teratogenic dose to be approximately 0.9 mg/kg pyrimethamine plus 18 mg/kg sulfadoxine. I...
Fansidar (sulfadoxine and pyrimethamine) should not be given to infants less than 2 months of age because of inadequate development of the glucuronide-forming enzyme system.
Clinical studies of Fansidar (sulfadoxine and pyrimethamine) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an e...
2023年5月9日 · Cyklokapron (tranexamic acid) is a man-made form of an amino acid (protein) called lysine used to prevent bleeding in people with hemophilia who need to have a tooth pulled. Cyklokapron is usually given just before the dental procedure, and daily for up to 8 days afterward. Cyklokapron is also used to treat heavy menstrual bleeding.
2022年10月5日 · In pediatric patients aged 4-16 years, initiate TRILETPAL at a daily dose of 8 to 10 mg/kg generally not to exceed600 mg/day, given twice a day. The target maintenance dose of TRILEPTAL should be achieved over 2 weeks, and is dependent upon patient weight, according to the following chart: 20 to 29 kg - 900 mg/day.
2022年3月8日 · Fludeoxyglucose F 18 Injection (fdg) is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2- [ 18 F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection. The active ingredient 2-deoxy-2- [ 18 F]fluoro-D ...
2024年5月6日 · Dosage for Hercessi. The dose of Hercessi for adjuvant treatment of HER2-overexpressing breast cancer is either: An initial dose of 4 mg/kg administered over 90-minutes as an intravenous (IV) infusion, then 2 mg/kg over 30-minute IV infusion weekly for 12 weeks (with paclitaxel or docetaxel) or 18 weeks (with docetaxel and carboplatin).
